Mason Heart Study With MCG

Paused

Conditions studied: Acute Myocardial Injuries

In brief

Heart disease is the number one cause of death in the United States, with over 650,000 deaths in 2019 alone. Many healthy individuals possess key risk factors for heart disease which include but are not limited to high blood pressure, high cholesterol, family history of heart disease, and diabetes. The Mason Heart Study-MCG (MHS-MCG) registry is designed to collect magnetocardiography (MCG) scans on a select group of healthy volunteers who work for the city of Mason, OH, with and without cardiac symptoms, illnesses, and/or risk factors. CardioFlux is used as a noninvasive MCG tool that analyzes and records the magnetic fields of the heart to detect various forms of heart disease. There will be a 12-month duration of the study where we propose to collect screening data from approximately 250 volunteers who present to the Genetesis facility for a 5-minute CardioFlux MCG scan. The volunteers will be contacted at intervals over a 1-year period for follow-up data and may choose whether or not they would like to provide follow-up data or participate in another scan.

Key facts

Study ID: NCT04732975
Run by: Genetesis Inc.
People needed: 250
Starts: 2020-12-14
Expected to finish: 2024-06-01
Last updated by the study team: 2023-02-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

≥ 18 years of age at the time of enrollment.

You may not qualify if…

< 18 years of age
Patients unable to fit into device
Non-ambulatory patients
Positive response on CardioFlux Pre-Screening Form
Patients with claustrophobia or unable to lie supine for 5 minutes
Pregnant women
Poor candidate for follow-up (e.g. no access to phone)
Prisoners

Where it is running

Genetesis Facility — Mason, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.